Gene: ERAP2
Official Full Name: endoplasmic reticulum aminopeptidase 2provided by HGNC
Gene Summary: This gene encodes a zinc metalloaminopeptidase of the M1 protease family that resides in the endoplasmic reticulum and functions in N-terminal trimming antigenic epitopes for presentation by major histocompatibility complex (MHC) class I molecules. Certain mutations in this gene are associated with the inflammatory arthritis syndrome ankylosing spondylitis and pre-eclampsia. This gene is located adjacent to a closely related aminopeptidase gene on chromosome 5. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04474 | ERAP2 Knockout cell line (HeLa) | Human | ERAP2 | 1:3~1:6 | Negative | Online Inquiry |
KO04475 | ERAP2 Knockout cell line (HCT 116) | Human | ERAP2 | 1:2~1:4 | Negative | Online Inquiry |
KO04476 | ERAP2 Knockout cell line (HEK293) | Human | ERAP2 | 1:3~1:6 | Negative | Online Inquiry |
KO04477 | ERAP2 Knockout cell line (A549) | Human | ERAP2 | 1:3~1:4 | Negative | Online Inquiry |
ERAP2 Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate the study of the endoplasmic reticulum aminopeptidase 2 (ERAP2) gene, which plays a critical role in the processing of peptides for MHC class I molecules. These knockout cell lines are engineered to have one or both alleles of the ERAP2 gene functionally disrupted, allowing researchers to investigate the biological functions of this gene and its implications in various immunological and pathological contexts.
The primary function of the ERAP2 enzyme involves the trimming of precursor peptides to appropriate lengths for loading onto major histocompatibility complex (MHC) molecules, thus influencing T-cell responses. By utilizing ERAP2 Gene Knockout Cell Lines, scientists can elucidate the role of ERAP2 in antigen presentation, autoimmune disorders, and cancer immunology, facilitating a deeper understanding of immune system regulation and potential therapeutic interventions.
This product holds significant scientific importance, as ERAP2 is implicated in several diseases, including inflammatory conditions and susceptibility to certain viral infections. The availability of these knockout cell lines can greatly enhance research endeavors aimed at unveiling the molecular underpinnings of these diseases and identifying innovative therapeutic targets.
Compared to conventional cell models, ERAP2 Gene Knockout Cell Lines provide precise genetic modifications that ensure consistent and reproducible results, minimizing variability inherent in wild-type cell lines. Furthermore, they offer the potential for high-throughput screening applications and drug discovery efforts, catering to the needs of researchers focused on developing novel therapies.
For researchers and clinicians invested in the intersection of immunology and genetics, these knockout cell lines serve as invaluable tools for exploring the nuances of immune response mechanisms. Our company's expertise in genetic engineering and commitment to delivering high-quality research tools positions us as a leader in the field. With ERAP2 Gene Knockout Cell Lines, you gain access to a resource that empowers innovations and accelerates discoveries in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.